RNAZ (STOCKS)
TransCode Therapeutics, Inc. Common Stock
$5.470000
+0.140000 (+2.63%)
Prev close: $5.330000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Philippe P. Calais
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $5.26M
- Employees
- 7
- P/E (TTM)
- -0.11
- P/B (TTM)
- 3.91
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
4
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2024 (Q4)
|
$-150.64 | $-91.68 | -58.9624 | -64.31% |
|
Sep 2024 (Q3)
|
$-147.84 | $-461.82 | +313.9752 | +67.99% |
|
Jun 2024 (Q2)
|
$-665.28 | $-546.64 | -118.6416 | -21.70% |
|
Mar 2024 (Q1)
|
$-498.96 | $-659.74 | +160.7760 | +24.37% |